You are hereHome >
Top Twenty Pay-For-Delay Drugs
- This practice has held back generic medicines used by patients with a wide range of serious or chronic conditions, ranging from cancer and heart disease, to depression and bacterial infection.
- These payoffs have delayed generic drugs for five years, on average, and as long as nine years.
- These brand-name drugs cost10 times more than their generic equivalents, on average, and as much as 33 times more.
- Combined, these brand-name drug companies have made an estimated$98 billion in total sales of these drugs while the generic versions were delayed.
Tools & Resources
Our Changing Relationship with Driving and the Implications for America’s FutureU.S. PIRG Education Fund
Read the Health Insurance 101 guide below, or download the PDF here.U.S. PIRG Education Fund
U.S. PIRG conducted a webinar with officials from 31 states on ways to improve online spending transparency
Tell your senator that patients can't afford to wait another day. We need to end "Pay for Delay" right now.
Your donation supports U.S. PIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.
Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.